Smart vaccine delivery based on microneedle arrays decorated with ultra-pH-responsive copolymers for cancer immunotherapy
Source abstract
Abstract
Despite the tremendous potential of DNA-based cancer vaccines, their efficacious delivery to antigen presenting cells to stimulate both humoral and cellular response remains a major challenge. Although electroporation-based transfection has improved performance, an optimal strategy for safe and pain-free vaccination technique remains elusive. Herein, we report a smart DNA vaccine delivery system in which nanoengineered DNA vaccine was laden on microneedles (MNs) assembled with layer-by-layer coating of ultra-pH-responsive OSM-(PEG-PAEU) and immunostimulatory adjuvant poly(I:C), a synthetic double stranded RNA. Transcutaneous application of MN patches onto the mice skin perforate the stratum corneum with minimal cell damage; subsequent disassembly at the immune-cell-rich epidermis/dermis allows the release of adjuvants and DNA vaccines, owing to the ultra-sharp pH-responsive nature of OSM-(PEG-PAEU). The released adjuvant and DNA vaccine can enhance dendritic cell maturation and induce type I interferons, and thereby produce antigen-specific antibody that can achieve the antibody-dependent cell-mediated cytotoxicity (ADCC) and CD8+ T cell to kill cancer cells. Strikingly, transcutaneous application of smart vaccine formulation in mice elicited 3-fold greater frequencies of Anti-OVA IgG1 serum antibody and 3-fold excess of cytotoxic CD8+ T cell than soluble DNA vaccine formulation. As a consequence, the formulation rejected the murine B16/OVA melanoma tumors in C57BL/6 mice through the synergistic activation of antigen-specific ADCC and cytotoxic CD8+ T cells. The maneuvered use of vaccine and adjuvant poly(I:C) in MNs induces humoral and cellular immunity, which provides a promising vaccine technology that shows improved efficacy, compliance, and safety.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Immunotherapy and Immune Responses · Dermatology and Skin Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Microenvironmental regulation of metastasis10.1038/nrc2618 ↗
2. Tailoring biomaterials for cancer immunotherapy: emerging trends and future outlook
3. Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy10.1038/nnano.2017.113 ↗
4. Engineering synthetic vaccines using cues from natural immunity10.1038/nmat3775 ↗
5. Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy10.1038/nbt.3071 ↗
6. An immunogenic personal neoantigen vaccine for patients with melanoma10.1038/nature22991 ↗
7. Particulate vaccines: on the quest for optimal delivery and immune response10.1016/j.drudis.2011.04.006 ↗
8. Reduction‐sensitive dextran nanogels aimed for intracellular delivery of antigens10.1002/adfm.201500894 ↗
9. A powerful CD8+ T-cell stimulating D-tetra-peptide hydrogel as a very promising vaccine adjuvant10.1002/adma.201601776 ↗
10. Immunological principles guiding the rational design of particles for vaccine delivery10.1021/acsnano.6b07343 ↗
11. Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T lymphocyte responses for DNA immunization10.1038/nbt0402-381 ↗
12. Enhancing immune responses using suicidal DNA vaccines10.1038/nbt0698-562 ↗
13. Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus10.1038/nbt1400 ↗
14. Polyplex-releasing microneedles for enhanced cutaneous delivery of DNA vaccine10.1016/j.jconrel.2014.01.016 ↗
15. Nutlin‐3a and cytokine Co‐loaded spermine‐modified acetalated dextran nanoparticles for cancer chemo‐immunotherapy
16. Engineering nanoparticle-coated bacteria as oral DNA vaccines for cancer immunotherapy10.1021/acs.nanolett.5b00570 ↗
17. A peptide-based nanofibrous hydrogel as a promising DNA nanovector for optimizing the efficacy of HIV vaccine10.1021/nl404560v ↗
18. One‐shot immunomodulatory nanodiamond agents for cancer immunotherapy10.1002/adma.201506232 ↗
19. Nanoparticulate delivery of cancer cell membrane elicits multiantigenic antitumor immunity
20. Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells10.1016/0092-8674(91)90647-H ↗
21. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns10.1038/nri2868 ↗
22. Dendritic cell-based cancer therapeutic vaccines10.1016/j.immuni.2013.07.004 ↗
23. Synthetic nanoparticles for vaccines and immunotherapy10.1021/acs.chemrev.5b00109 ↗
24. Multistaged nanovaccines based on porous Silicon@Acetalated Dextran@Cancer cell membrane for cancer immunotherapy
25. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules10.1021/nn900715g ↗
26. Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy10.1021/acs.nanolett.6b03329 ↗
27. Injectable cryogel-based whole-cell cancer vaccines10.1038/ncomms8556 ↗
28. Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccination10.1002/adfm.201201512 ↗
29. Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery10.1021/nn302639r ↗
30. Nano-layered microneedles for transcutaneous delivery of polymer nanoparticles and plasmid DNA10.1002/adma.201001525 ↗
31. Structure-based programming of lymph-node targeting in molecular vaccines10.1038/nature12978 ↗
32. Microneedles for drug and vaccine delivery10.1016/j.addr.2012.04.005 ↗
33. Effective humoral immune response from a H1N1 DNA vaccine delivered to the skin by microneedles coated with PLGA-based cationic nanoparticles10.1016/j.jconrel.2017.04.027 ↗
34. Enhanced cancer immunotherapy by microneedle patch-assisted delivery of anti-PD1 antibody10.1021/acs.nanolett.5b05030 ↗
35. Hypoxia and H2O2 dual-sensitive vesicles for enhanced glucose-responsive insulin delivery10.1021/acs.nanolett.6b03848 ↗
36. Polymer multilayer tattooing for enhanced DNA vaccination10.1038/nmat3550 ↗
37. Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-d,l-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses10.1021/nn304235j ↗
38. Toll-like receptor 3 promotes cross-priming to virus-infected cells10.1038/nature03326 ↗
39. Assembly and immunological processing of polyelectrolyte multilayers composed of antigens and adjuvants10.1021/acsami.6b06275 ↗
40. Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method10.1016/j.jconrel.2010.11.021 ↗
41. Microneedle arrays coated with charge reversal pH-sensitive copolymers improve antigen presenting cells-homing DNA vaccine delivery and immune responses10.1016/j.jconrel.2017.11.025 ↗
42. Mussel-inspired polydopamine: a biocompatible and ultrastable coating for nanoparticles in vivo10.1021/nn404117j ↗
43. Injectable hydrogels for sustained release of therapeutic agents10.1016/j.jconrel.2017.08.006 ↗
44. Enhancing neurogenesis and angiogenesis with target delivery of stromal cell derived factor-1α using a dual ionic pH-sensitive copolymer10.1016/j.biomaterials.2015.05.025 ↗
45. Endosomal size and membrane leakiness influence proton sponge-based rupture of endosomal vesicles10.1021/acsnano.7b07583 ↗
46. Analgesic microneedle patch for neuropathic pain therapy10.1021/acsnano.6b06104 ↗
47. Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines10.1038/nmat1075 ↗